{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T08:09:36Z","timestamp":1778918976725,"version":"3.51.4"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T00:00:00Z","timestamp":1775260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T00:00:00Z","timestamp":1775260800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"This work was supported by the Zhejiang Medical and Health Science and Technology Program","award":["2025KY1974, 2024KY1864, 2025KY504, 2025KY1975, 2024KY1867, 2024KY587"],"award-info":[{"award-number":["2025KY1974, 2024KY1864, 2025KY504, 2025KY1975, 2024KY1867, 2024KY587"]}]},{"name":"This work was supported by the Zhejiang Medical and Health Science and Technology Program","award":["2025KY1974, 2024KY1864, 2025KY504, 2025KY1975, 2024KY1867, 2024KY587"],"award-info":[{"award-number":["2025KY1974, 2024KY1864, 2025KY504, 2025KY1975, 2024KY1867, 2024KY587"]}]},{"name":"This work was supported by the Zhejiang Medical and Health Science and Technology Program","award":["2025KY1974, 2024KY1864, 2025KY504, 2025KY1975, 2024KY1867, 2024KY587"],"award-info":[{"award-number":["2025KY1974, 2024KY1864, 2025KY504, 2025KY1975, 2024KY1867, 2024KY587"]}]},{"name":"This work was supported by the Zhejiang Medical and Health Science and Technology Program","award":["2025KY1974, 2024KY1864, 2025KY504, 2025KY1975, 2024KY1867, 2024KY587"],"award-info":[{"award-number":["2025KY1974, 2024KY1864, 2025KY504, 2025KY1975, 2024KY1867, 2024KY587"]}]},{"name":"This work was supported by the Zhejiang Medical and Health Science and Technology Program","award":["2025KY1974, 2024KY1864, 2025KY504, 2025KY1975, 2024KY1867, 2024KY587"],"award-info":[{"award-number":["2025KY1974, 2024KY1864, 2025KY504, 2025KY1975, 2024KY1867, 2024KY587"]}]},{"name":"This work was supported by the Zhejiang Medical and Health Science and Technology Program","award":["2025KY1974, 2024KY1864, 2025KY504, 2025KY1975, 2024KY1867, 2024KY587"],"award-info":[{"award-number":["2025KY1974, 2024KY1864, 2025KY504, 2025KY1975, 2024KY1867, 2024KY587"]}]},{"name":"This work was supported by the Zhejiang Medical and Health Science and Technology Program","award":["2025KY1974, 2024KY1864, 2025KY504, 2025KY1975, 2024KY1867, 2024KY587"],"award-info":[{"award-number":["2025KY1974, 2024KY1864, 2025KY504, 2025KY1975, 2024KY1867, 2024KY587"]}]},{"name":"This work was supported by the Zhejiang Medical and Health Science and Technology Program","award":["2025KY1974, 2024KY1864, 2025KY504, 2025KY1975, 2024KY1867, 2024KY587"],"award-info":[{"award-number":["2025KY1974, 2024KY1864, 2025KY504, 2025KY1975, 2024KY1867, 2024KY587"]}]},{"name":"This work was supported by the Zhejiang Medical and Health Science and Technology Program","award":["2025KY1974, 2024KY1864, 2025KY504, 2025KY1975, 2024KY1867, 2024KY587"],"award-info":[{"award-number":["2025KY1974, 2024KY1864, 2025KY504, 2025KY1975, 2024KY1867, 2024KY587"]}]},{"name":"This work was supported by the Zhejiang Medical and Health Science and Technology Program","award":["2025KY1974, 2024KY1864, 2025KY504, 2025KY1975, 2024KY1867, 2024KY587"],"award-info":[{"award-number":["2025KY1974, 2024KY1864, 2025KY504, 2025KY1975, 2024KY1867, 2024KY587"]}]},{"name":"This work was supported by the Zhejiang Medical and Health Science and Technology Program","award":["2025KY1974, 2024KY1864, 2025KY504, 2025KY1975, 2024KY1867, 2024KY587"],"award-info":[{"award-number":["2025KY1974, 2024KY1864, 2025KY504, 2025KY1975, 2024KY1867, 2024KY587"]}]},{"name":"Lishui Public Welfare Technology Application Research Project","award":["2024GYX29, 2024SJZC119, 2024SJZC115"],"award-info":[{"award-number":["2024GYX29, 2024SJZC119, 2024SJZC115"]}]},{"name":"Zhejiang Public Welfare Technology Application Research Project","award":["LBY24H180007"],"award-info":[{"award-number":["LBY24H180007"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cell Biochem"],"DOI":"10.1007\/s11010-026-05509-x","type":"journal-article","created":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T10:00:23Z","timestamp":1775296823000},"page":"2159-2172","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["CREB1-ROC1 axis drives bladder cancer progression under hypoxic conditions"],"prefix":"10.1007","volume":"481","author":[{"given":"Zhenchao","family":"Sun","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yingyu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shengjie","family":"You","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qingfen","family":"Ji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pengfei","family":"Bao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huijiang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoqing","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junjie","family":"Ye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peng","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qi","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,4,4]]},"reference":[{"key":"5509_CR1","first-page":"10","volume":"75","author":"RL Siegel","year":"2025","unstructured":"Siegel RL, Kratzer TB, Giaquinto AN, Sung H, Jemal A (2025) Cancer statistics, 2025. CA Cancer J Clin 75:10\u201345","journal-title":"CA Cancer J Clin"},{"key":"5509_CR2","first-page":"45","volume":"38","author":"L Solano","year":"2025","unstructured":"Solano L (2025) Bladder cancer. JAAPA-J Am Acad Phys 38:45\u201346","journal-title":"JAAPA-J Am Acad Phys"},{"key":"5509_CR3","doi-asserted-by":"crossref","unstructured":"Shukla CP, Jain NK, O\u2019Donnell MA, Vachhani KV, Patel R, Patel J, Modi R, Dheeraj A, Lee JM, Rolig A, Malhotra SV, Khamar B (2025) Desmocollin-3 and bladder cancer. Diseases-Basel 13","DOI":"10.3390\/diseases13050131"},{"key":"5509_CR4","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-59888-8","volume":"16","author":"H Yang","year":"2025","unstructured":"Yang H, Song H, Yip E, Gilpatrick T, Chang K, Allegakoen P, Lu KL, Hui K, Pham JH, Kasap C, Kumar V, Gayle J, Stohr BA, Cornelia DC, Wiita AP, Meng MV, Chou J, Porten SP, Huang FW (2025) Bladder cancer variants share aggressive features including a CA125\u2009+\u2009cell state and targetable TM4SF1 expression. Nat Commun 16:5312","journal-title":"Nat Commun"},{"key":"5509_CR5","first-page":"10","volume":"32","author":"Q Fang","year":"2025","unstructured":"Fang Q, You C, Xiao X, Liu Y, Yang W, Li Q, Qing L, Dong Z (2025) Mevalonate metabolic reprogramming drives cisplatin resistance in bladder cancer. Mechanisms and Therapeutic Targeting, Protein Peptide Lett. 32:10\u20132174","journal-title":"Mechanisms and Therapeutic Targeting, Protein Peptide Lett."},{"key":"5509_CR6","doi-asserted-by":"publisher","first-page":"29392","DOI":"10.1021\/acsami.5c05133","volume":"17","author":"W Ouyang","year":"2025","unstructured":"Ouyang W, Wang H, Zhao Z, Wang M, Li G, Wu S, Wang X, Liu J, Li J, Liu H (2025) Light-responsive Ru-Se coordinated nanoreactor spatiotemporally relieves hypoxia for photodynamic therapy of bladder cancer. ACS Appl Mater Inter 17:29392\u201329406","journal-title":"ACS Appl Mater Inter"},{"key":"5509_CR7","doi-asserted-by":"publisher","first-page":"3273","DOI":"10.21037\/tcr-23-2375","volume":"13","author":"F Xu","year":"2024","unstructured":"Xu F, Yao X, Zhou N, Hu Z, Guo C, Zhou H, Yan X (2024) Tumor hypoxia in immune infiltration and prognosis of bladder cancer. Transl Cancer Res 13:3273\u20133284","journal-title":"Transl Cancer Res"},{"key":"5509_CR8","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-024-03570-4","volume":"24","author":"Y Yan","year":"2024","unstructured":"Yan Y, Huang Z, Zhu Z, Wang Y, Cao X, Yang C, Jiang J, Xia S, Shen B (2024) IMP2 drives chemoresistance by repressing cisplatin-induced apoptosis and ferroptosis via activation of IPO4 and SLC7A11 under hypoxia in bladder cancer. Cancer Cell Int 24:386","journal-title":"Cancer Cell Int"},{"key":"5509_CR9","doi-asserted-by":"publisher","first-page":"2973","DOI":"10.1016\/j.molcel.2025.07.001","volume":"85","author":"AM Minikes","year":"2025","unstructured":"Minikes AM, Liu P, Wang H, Hu J, Alwaseem H, Li Y, Jiang X (2025) HIF-independent oxygen sensing via KDM6A regulates ferroptosis. Mol Cell 85:2973\u20132987","journal-title":"Mol Cell"},{"key":"5509_CR10","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-023-06189-x","volume":"14","author":"Q Zhou","year":"2023","unstructured":"Zhou Q, Huang W, Xiong J, Guo B, Wang X, Guo J (2023) CDCA8 promotes bladder cancer survival by stabilizing HIF1alpha expression under hypoxia. Cell Death Dis 14:658","journal-title":"Cell Death Dis"},{"key":"5509_CR11","doi-asserted-by":"publisher","DOI":"10.2174\/0115665232365878250503091118","author":"R Kaviyaprabha","year":"2025","unstructured":"Kaviyaprabha R, Muthusami S, Miji TV, Arulselvan P, Bharathi M (2025) Elucidating the predominant role of AEBP1 in different types of cancers with a focus on glioblastoma progression - a review. Curr Gene Ther. https:\/\/doi.org\/10.2174\/0115665232365878250503091118","journal-title":"Curr Gene Ther"},{"key":"5509_CR12","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1038\/bjc.2015.444","volume":"114","author":"W Wang","year":"2016","unstructured":"Wang W, Chen H, Liu Z, Qu P, Lan J, Chen H, Zou L, Qiu J (2016) Regulator of cullins-1 expression knockdown suppresses the malignant progression of muscle-invasive transitional cell carcinoma by regulating mTOR\/DEPTOR pathway. Br J Cancer 114:305\u2013313","journal-title":"Br J Cancer"},{"key":"5509_CR13","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s13000-020-00947-7","volume":"15","author":"DR Al-Sharaky","year":"2020","unstructured":"Al-Sharaky DR, Kandil M, Aiad H, El-Hosary EM, Alagizy HA, Elshenawy MA, El-Rebey HS (2020) ROC-1, P21 and CAIX as markers of tumor aggressiveness in bladder carcinoma in Egyptian patients. Diagn Pathol 15:33","journal-title":"Diagn Pathol"},{"key":"5509_CR14","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s12935-021-01775-5","volume":"21","author":"W Wang","year":"2021","unstructured":"Wang W, Qiu J, Qu P, Chen H, Lan J, Chen H, Li L, Gu M (2021) Regulator of cullins-1 (ROC1) negatively regulates the Gli2 regulator SUFU to activate the hedgehog pathway in bladder cancer. Cancer Cell Int 21:75","journal-title":"Cancer Cell Int"},{"key":"5509_CR15","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0062734","volume":"8","author":"W Wang","year":"2013","unstructured":"Wang W, Liu Z, Qu P, Zhou Z, Zeng Y, Fan J, Liu Y, Guo Y, Qiu J (2013) Knockdown of regulator of cullins-1 (ROC1) expression induces bladder cancer cell cycle arrest at the G2 phase and senescence. PLoS One 8:e62734","journal-title":"PLoS One"},{"key":"5509_CR16","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1186\/s13046-021-01935-5","volume":"40","author":"Q Wu","year":"2021","unstructured":"Wu Q, Zhou X, Li P, Ding M, You S, Xu Z, Ye J, Chen X, Tan M, Wang J, Wang W, Qiu J (2021) ROC1 promotes the malignant progression of bladder cancer by regulating p-I\u03baB\u03b1\/NF-\u03baB signaling. J Experimental Clin Cancer Res: CR 40:158","journal-title":"J Experimental Clin Cancer Res: CR"},{"key":"5509_CR17","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.semcancer.2021.10.002","volume":"85","author":"M Ivan","year":"2022","unstructured":"Ivan M, Fishel ML, Tudoran OM, Pollok KE, Wu X, Smith PJ (2022) Hypoxia signaling: challenges and opportunities for cancer therapy. Semin Cancer Biol 85:185\u2013195","journal-title":"Semin Cancer Biol"},{"key":"5509_CR18","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14092291","author":"RA Castillo-Rodriguez","year":"2022","unstructured":"Castillo-Rodriguez RA, Trejo-Solis C, Cabrera-Cano A, Gomez-Manzo S, Davila-Borja VM (2022) Hypoxia as a modulator of inflammation and immune response in cancer. Cancers. https:\/\/doi.org\/10.3390\/cancers14092291","journal-title":"Cancers"},{"key":"5509_CR19","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1002\/cac2.12158","volume":"41","author":"JZ Wang","year":"2021","unstructured":"Wang JZ, Zhu W, Han J, Yang X, Zhou R, Lu HC, Yu H, Yuan WB, Li PC, Tao J, Lu Q, Wei JF, Yang H (2021) The role of the HIF-1alpha\/ALYREF\/PKM2 axis in glycolysis and tumorigenesis of bladder cancer. Cancer Commun 41:560\u2013575","journal-title":"Cancer Commun"},{"key":"5509_CR20","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1186\/s12885-021-09009-7","volume":"21","author":"V Smith","year":"2021","unstructured":"Smith V, Mukherjee D, Lunj S, Choudhury A, Hoskin P, West C, Illidge T (2021) The effect of hypoxia on PD-L1 expression in bladder cancer. BMC Cancer 21:1271","journal-title":"BMC Cancer"},{"key":"5509_CR21","doi-asserted-by":"publisher","first-page":"8887437","DOI":"10.1155\/2021\/8887437","volume":"2021","author":"X Mao","year":"2021","unstructured":"Mao X, Nanzhang J, Xiao H, Wu, Ding K (2021) Hypoxia-induced autophagy enhances cisplatin resistance in human bladder cancer cells by targeting hypoxia-inducible factor-1alpha. J Immunol Res 2021:8887437","journal-title":"J Immunol Res"},{"key":"5509_CR22","first-page":"3842","volume":"16","author":"L Guo","year":"2018","unstructured":"Guo L, Yin M, Wang Y (2018) CREB1, a direct target of miR-122, promotes cell proliferation and invasion in bladder cancer. Oncol Lett 16:3842\u20133848","journal-title":"Oncol Lett"},{"key":"5509_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2015.274","volume":"7","author":"X Xu","year":"2016","unstructured":"Xu X, Zhu Y, Liang Z, Li S, Xu X, Wang X, Wu J, Hu Z, Meng S, Liu B, Qin J, Xie L, Zheng X (2016) c-Met and CREB1 are involved in miR-433-mediated inhibition of the epithelial-mesenchymal transition in bladder cancer by regulating Akt\/GSK-3beta\/Snail signaling. Cell Death Dis 7:e2088","journal-title":"Cell Death Dis"}],"container-title":["Molecular and Cellular Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-026-05509-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11010-026-05509-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-026-05509-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T07:28:27Z","timestamp":1778916507000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11010-026-05509-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,4]]},"references-count":23,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,5]]}},"alternative-id":["5509"],"URL":"https:\/\/doi.org\/10.1007\/s11010-026-05509-x","relation":{},"ISSN":["1573-4919"],"issn-type":[{"value":"1573-4919","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,4]]},"assertion":[{"value":"11 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The present work followed the Declaration of Helsinki and gained approval from ethics committee of Lishui Hospital Affiliated Hospital of Wenzhou Medical University (approval number: 20200103).\u00a0The animal experiments gained approval from ethics committee of Lishui Hospital Affiliated Hospital of Wenzhou Medical University (approval number: AB20200103Z).\u00a0The methods were conducted following corresponding guidelines and regulations.\u00a0The methods were reported following ARRIVE guidelines.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}